PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
12921485-6	2003	Several potent, high affinity cholecystokinin (CCK)-2 receptor antagonists have recently been identified such as L-365260, YM-022, RP-73870, S-0509, spiroglumide and itriglumide (CR-2945).	YM 022	123-129	cholecystokinin B receptor	Homo sapiens	30-62	
8886928-0	1996	Antagonistic effect of YM022, an antiulcer agent in rats, on human cholecystokinin (CCK)B/gastrin receptor.	YM 022	23-28	cholecystokinin B receptor	Homo sapiens	90-106	
8698625-0	1996	Antiproliferative effect of a novel cholecystokinin-B/gastrin receptor antagonist, YM022.	YM 022	83-88	cholecystokinin B receptor	Homo sapiens	54-70	
31430329-8	2019	The addition of YM022, an antagonist of the gastrin receptor cholecystokinin B receptor (CCKBR), together with gastrin eliminated these effects, verifying that the effects of gastrin are mediated through CCKBR.CCKBR is expressed in somatostatin-expressing delta cells in islets from all donors.	YM 022	16-21	cholecystokinin B receptor	Homo sapiens	44-60	
31430329-8	2019	The addition of YM022, an antagonist of the gastrin receptor cholecystokinin B receptor (CCKBR), together with gastrin eliminated these effects, verifying that the effects of gastrin are mediated through CCKBR.CCKBR is expressed in somatostatin-expressing delta cells in islets from all donors.	YM 022	16-21	cholecystokinin B receptor	Homo sapiens	61-87	
31430329-8	2019	The addition of YM022, an antagonist of the gastrin receptor cholecystokinin B receptor (CCKBR), together with gastrin eliminated these effects, verifying that the effects of gastrin are mediated through CCKBR.CCKBR is expressed in somatostatin-expressing delta cells in islets from all donors.	YM 022	16-21	cholecystokinin B receptor	Homo sapiens	89-94	
31430329-8	2019	The addition of YM022, an antagonist of the gastrin receptor cholecystokinin B receptor (CCKBR), together with gastrin eliminated these effects, verifying that the effects of gastrin are mediated through CCKBR.CCKBR is expressed in somatostatin-expressing delta cells in islets from all donors.	YM 022	16-21	cholecystokinin B receptor	Homo sapiens	204-209	
31430329-8	2019	The addition of YM022, an antagonist of the gastrin receptor cholecystokinin B receptor (CCKBR), together with gastrin eliminated these effects, verifying that the effects of gastrin are mediated through CCKBR.CCKBR is expressed in somatostatin-expressing delta cells in islets from all donors.	YM 022	16-21	cholecystokinin B receptor	Homo sapiens	204-209